GIONCO DAVID (Chief Accounting Officer) sold 1.9% of their position (4.52K shares) of STEMLINE THERAPEUTICS INC on the open market
Open‑market sale worth $49.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 1/3/2020ACC: 0001104659-20-000979
Officer· Chief Accounting Officer
Since Feb 2019
-4.52K
Net shares
Net seller
$49.0K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
4.52K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−421.00
Price / share
$10.58
Trade value
$4.45K
% of position
0.2%
12/23/2019
239.94K→239.52K
Common Stock
Direct
Shares
−2.39K
Price / share
$10.97
Trade value
$26.20K
% of position
1.0%
12/24/2019
239.52K→237.13K
Common Stock
Direct
Shares
−1.51K
Price / share
$10.75
Trade value
$16.24K
% of position
0.6%
12/26/2019
237.13K→235.62K
Common Stock
Direct
Shares
−197.00
Price / share
$10.48
Trade value
$2.06K
% of position
0.1%
12/27/2019
235.62K→235.42K
Total
Net shares
−4.52K
Net value
-$48.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/23/2019 | S · Sale | −421.00 | $10.58 | $4.45K | 0.2% | 239.94K | 239.52K |
| Common Stock Direct | 12/24/2019 | S · Sale | −2.39K | $10.97 | $26.20K | 1.0% | 239.52K | 237.13K |
| Common Stock Direct | 12/26/2019 | S · Sale | −1.51K | $10.75 | $16.24K | 0.6% | 237.13K | 235.62K |
| Common Stock Direct | 12/27/2019 | S · Sale | −197.00 | $10.48 | $2.06K | 0.1% | 235.62K | 235.42K |
| Total | −4.52K | -$48.96K | ||||||
Derivative Transactions0
No derivative transactions reported